Viagra sales in Norway reached almost five million tablets last year, according to figures from the Norwegian Institute of Public Health (Folkehelseinstituttet) and the Norwegian Pharmacy Association (Apotekforeningen) reported by P4. The increase, close to 28 percent over five years, points to a broader shift in how erectile dysfunction medication is used, discussed and accessed in Norway.
The figures show that Norwegians bought 3,503,320 tablets of 50 mg Viagra on prescription and 1,452,224 tablets of 50 mg Viagra without prescription in 2025. In total, that amounts to 4,955,544 tablets, bringing sales close to a symbolic threshold of five million.
Viagra sales in Norway show a clear shift in demand
The rise does not appear to be limited to older men, who have traditionally been associated with erectile dysfunction medication. According to Apotek 1 pharmacist Per Carlsson, cited by P4, the typical customer is no longer mainly a man over 50. Pharmacies are now seeing more men in their 30s, including fathers with family responsibilities.
That change matters because it suggests that the growing market is not only linked to ageing or long-term physical conditions. It may also reflect a wider social and psychological pattern, including stress, performance pressure and changing expectations around sex.
In Norway, sildenafil, the active ingredient in Viagra, can be sold without prescription under a regulated pharmacy guidance model. The Norwegian Medical Products Agency (Direktoratet for medisinske produkter) considers non-prescription sildenafil suitable for self-treatment for men over 18, provided that customers receive guidance from a pharmacist.
This model was designed to make treatment more accessible while keeping a level of medical screening. It also reduces the stigma of discussing erectile problems with a doctor. But the latest figures raise a separate question: whether easier access is also normalising use among men who may not medically need the drug.
Pharmacists see younger customers and more stress-related use
Clinical sexologist Tore Holte Follestad told P4 that many men may be using Viagra or similar medication unnecessarily. In his view, erectile problems are often linked to performance anxiety rather than a physical inability to have an erection.
He suggested two basic questions men should ask themselves before turning to medication: whether they get morning erections, and whether they can get an erection when alone and masturbating. If the answer to either question is yes, he said, they may not need Viagra or another potency drug.
The point is not that erectile medication is ineffective. Sildenafil and related medicines are established treatments for erectile dysfunction. Norway’s public health information service Helsenorge notes that such medicines can help by increasing blood flow to the penis, and that they are used by some men with erection problems.
But the Norwegian figures also show how sexual health is increasingly shaped by lifestyle pressures. Carlsson pointed to stress as one possible factor. Follestad made a similar point, arguing that men may feel that they are not allowed to have a bad day or simply not want sex.
That observation places the issue beyond pharmacy statistics. It touches on masculinity, mental health and the way sexual performance is understood among younger adults. In that sense, the rise in Viagra sales may be partly medical, partly cultural.
Non-prescription Viagra still requires caution
The fact that Viagra can be bought without prescription in Norway does not mean it is risk-free. Non-prescription sildenafil is subject to pharmacy guidance, and customers may be referred to a doctor if certain health conditions or warning signs are present.
Medical guidance also stresses that sildenafil is intended for men with erectile dysfunction, not for those without impotence. The drug should not be used together with nitrates or certain other substances because the combination can cause a dangerous fall in blood pressure. It is also not suitable for men for whom sexual activity is medically inadvisable, including some patients with serious cardiovascular conditions.
These restrictions are important because erectile problems can sometimes be a sign of underlying health issues, including cardiovascular disease, diabetes or side effects from medication. For that reason, repeated or sudden erectile problems should not be treated only as an inconvenience to solve privately.
The Norwegian model tries to balance privacy and safety. It allows men to seek help more discreetly while keeping pharmacists involved in basic risk assessment. The growing number of tablets sold suggests that this access route is widely used.
A Nordic debate about sexual health and performance pressure
The Norwegian data may also be relevant beyond Norway. Across the Nordic countries, public health systems increasingly frame sexual health as part of broader wellbeing rather than a private or marginal issue. The rise in erectile dysfunction medication use among younger men fits into wider debates on mental health, work-life balance and the pressures created by digital culture.
For health services, the challenge is not only to regulate access to medication. It is also to ensure that men receive credible information about when treatment is useful, when psychological support may be more appropriate, and when a medical check-up is needed.
The increase in Viagra sales in Norway therefore tells a larger story. It shows that a once highly stigmatised drug has become more accessible and more common. But it also raises a quieter question for Nordic public health: whether easier access to medication is being matched by enough attention to stress, anxiety and the social expectations behind the demand.
